Journal of affective disorders

Evening preference as a distinct type of bipolar disorder

Updated

Abstract

27% of bipolar disorder patients reported an evening chronotype.

  • Evening chronotype was found in 24% of a matched sub-sample of bipolar disorder patients compared to 5% of controls.
  • Bipolar disorder patients with an evening chronotype were generally younger and had an earlier onset of the disorder.
  • Those with an evening chronotype experienced more prior depressive and manic episodes and had higher rates of rapid cycling.
  • Evening chronotype was associated with a history of suicide attempts, anxiety disorders, and substance use disorders.
  • Medical conditions such as hypertension, migraine, asthma, and obstructive sleep apnea were also linked to evening chronotype.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of Competing Interest Dr. Romo-Nava reports support from the Brain & Behavior Research Foundation NARSAD Young Investigator Award; receiving nonfinancial support from Soterix Medical outside the submitted work; and having patent 62 581 968 pending. dr. McElroy reported receiving grants and personal fees from Allergan, Avanir, Myriad, Shire, and Sunovion; receiving grants from Brainsway, Marriott Foundation, Medibio, Neurocrine, and Novo Nordisk; receiving personal fees from Bracket, F. Hoffmann-LaRoche Limited, Mitsubishi Tanabe Pharma America, and Opiant; being a consultant to or member of the scientific advisory boards of Bracket, MedAvante, Naurex, Shire, and Sunovion; being a principal or co-investigator on studies sponsored by the Agency for Healthcare Research & Quality, AstraZeneca, Cephalon, Forest, Marriott Foundation, the National Institute of Mental Health, Orexigen Therapeutics Inc, Shire, and Takeda Pharmaceutical Company Ltd; being an inventor on US Patent 6 323 236 B2; and receiving payments from Johnson & Johnson, which has exclusive patent rights. dr.. Frye reported receiving grants from the Marriott Foundation during the conduct of the study; receiving grants from the National Institute of Alcohol Abuse and Alcoholism and National Institute of Mental Health, National Institutes of Health, Assurex Health, Myriad, and Pfizer; being a consultant to Janssen Global Services LLC; receiving other support from Mitsubishi Tanabe Pharma Corporation, Myriad, Sunovion, and Teva Pharmaceuticals; receiving travel and hotel honoraria from CME Outfitters to give a lecture for continuing medical education credit and receiving support for a presentation from Sunovion. No other disclosures are reported.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free